Dr. Moll's challenge

Pininvest Analysis on Health Care

The achievements of Fred Moll in medical robotics are close to legendary but the collaboration of Dr. Moll with Johnson & Johnson, may raise the bar, with real-time management of the data feeds informing the robotics applications - the next frontier...

6 more articles in Medical Robotics
1 more article in Chronic Diseases
3 more articles in Pharmaceuticals Majors

Challenging times for Celgene

Pininvest Analysis on Health Care

Revlimid, a drug for multiple myeloma, is the main stay of Celgene’s business (approx. 2/3 of 2017 $13bn turnover) – the drug also highlights the challenges of large biopharmaceutical companies priced for growth